Current challenges for cancer vaccine adjuvant development.

about

Current challenges for cancer vaccine adjuvant development.

Item

http://www.wikidata.org/entity/Q48160317

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Current challenges for cancer vaccine adjuvant development.

@en

Current challenges for cancer vaccine adjuvant development.

@nl

type

Item

label

Current challenges for cancer vaccine adjuvant development.

@en

Current challenges for cancer vaccine adjuvant development.

@nl

prefLabel

Current challenges for cancer vaccine adjuvant development.

@en

Current challenges for cancer vaccine adjuvant development.

@nl

P1476

Current challenges for cancer vaccine adjuvant development

@en

P2093

Abhishek K Svrivastava

http://www.w3.org/2001/XMLSchema#string

Hampartsoum Barsoumian

http://www.w3.org/2001/XMLSchema#string

Lalit Batra

http://www.w3.org/2001/XMLSchema#string

William S Bowen

http://www.w3.org/2001/XMLSchema#string

P2860

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

Neoantigen-based cancer immunotherapy

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

Cancer vaccines

TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes

Nivolumab plus ipilimumab in advanced melanoma.

Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment

Approaching the asymptote? Evolution and revolution in immunology

P304

207-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14760584.2018.1434000

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Haval Shirwan

P577

2018-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29372660

http://www.w3.org/2001/XMLSchema#string

P932

6093214

http://www.w3.org/2001/XMLSchema#string